Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Offner

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Hematology (Amsterdam, Netherlands)|July 18, 2014
Symptoms and toxicity of rituximab maintenance relative to observation following immunochemotherapy in patients with follicular lymphomaXiaolei Zhou, Jianmin Wang, Jessica Zhang, et al.
Intensive Care Medicine|May 19, 2010
Impact of organ dysfunction on mortality in ICU patients with hematologic malignanciesDominique M Vandijck, Pieter O Depuydt, Fritz C Offner, et al.
Intensive Care Medicine|November 26, 2005
Outcome in severely ill patients with hematological malignancies who received intravenous chemotherapy in the intensive care unitDominique D Benoit, Pieter O Depuydt, Koenraad H Vandewoude, et al.
Leukemia|February 16, 2011
Laser microdissection for the assessment of the clonal relationship between chronic lymphocytic leukemia/small lymphocytic lymphoma and proliferating B cells within lymph node pseudofolliclesM L Vandewoestyne, V C Pede, K Y Lambein, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 27, 2005
Outcome in critically ill medical patients treated with renal replacement therapy for acute renal failure: comparison between patients with and those without haematological malignanciesDominique D Benoit, Eric A Hoste, Pieter O Depuydt, et al.
Intensive Care Medicine|January 25, 2008
Impact of recent intravenous chemotherapy on outcome in severe sepsis and septic shock patients with hematological malignanciesDominique M Vandijck, Dominique D Benoit, Pieter O Depuydt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2008
Phase III study of R-CVP compared with cyclophosphamide, vincristine, and prednisone alone in patients with previously untreated advanced follicular lymphomaRobert Marcus, Kevin Imrie, Philippe Solal-Celigny, et al.
Intensive Care Medicine|March 23, 2005
Documented and clinically suspected bacterial infection precipitating intensive care unit admission in patients with hematological malignancies: impact on outcomeDominique D Benoit, Pieter O Depuydt, Renaat A Peleman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2015
Randomized Phase II Trial Comparing Obinutuzumab (GA101) With Rituximab in Patients With Relapsed CD20+ Indolent B-Cell Non-Hodgkin Lymphoma: Final Analysis of the GAUSS StudyLaurie H Sehn, Andre Goy, Fritz C Offner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2021
Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell-Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I TrialMartin Hutchings, Franck Morschhauser, Gloria Iacoboni, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Hematology (Amsterdam, Netherlands)|July 18, 2014
Symptoms and toxicity of rituximab maintenance relative to observation following immunochemotherapy in patients with follicular lymphomaXiaolei Zhou, Jianmin Wang, Jessica Zhang, et al.
Intensive Care Medicine|May 19, 2010
Impact of organ dysfunction on mortality in ICU patients with hematologic malignanciesDominique M Vandijck, Pieter O Depuydt, Fritz C Offner, et al.
Intensive Care Medicine|November 26, 2005
Outcome in severely ill patients with hematological malignancies who received intravenous chemotherapy in the intensive care unitDominique D Benoit, Pieter O Depuydt, Koenraad H Vandewoude, et al.
Leukemia|February 16, 2011
Laser microdissection for the assessment of the clonal relationship between chronic lymphocytic leukemia/small lymphocytic lymphoma and proliferating B cells within lymph node pseudofolliclesM L Vandewoestyne, V C Pede, K Y Lambein, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 27, 2005
Outcome in critically ill medical patients treated with renal replacement therapy for acute renal failure: comparison between patients with and those without haematological malignanciesDominique D Benoit, Eric A Hoste, Pieter O Depuydt, et al.
Intensive Care Medicine|January 25, 2008
Impact of recent intravenous chemotherapy on outcome in severe sepsis and septic shock patients with hematological malignanciesDominique M Vandijck, Dominique D Benoit, Pieter O Depuydt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2008
Phase III study of R-CVP compared with cyclophosphamide, vincristine, and prednisone alone in patients with previously untreated advanced follicular lymphomaRobert Marcus, Kevin Imrie, Philippe Solal-Celigny, et al.
Intensive Care Medicine|March 23, 2005
Documented and clinically suspected bacterial infection precipitating intensive care unit admission in patients with hematological malignancies: impact on outcomeDominique D Benoit, Pieter O Depuydt, Renaat A Peleman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2015
Randomized Phase II Trial Comparing Obinutuzumab (GA101) With Rituximab in Patients With Relapsed CD20+ Indolent B-Cell Non-Hodgkin Lymphoma: Final Analysis of the GAUSS StudyLaurie H Sehn, Andre Goy, Fritz C Offner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2021
Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell-Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I TrialMartin Hutchings, Franck Morschhauser, Gloria Iacoboni, et al.
Pageof 2